Biogen Names Christopher Viehbacher President and Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Biogen (BIIB) new CEO could be 'just what BIIB needs'
November 10, 2022 1:04 PM ESTBiogen (NASDAQ: BIIB) announced that the former CEO of Sanofi, Christopher Viehbacher, will take over as its President, CEO, and member of the Board of Directors effective on November 14.
Following the announcement, Cowen analyst Phil Nadeau told investors in a note that although his tenure at Sanofi ended abruptly, a strong CEO personality aligned with... More
